Atlas Trials

Biomed Industries, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biomed Industries, Inc.

RecordFirmDate
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome (NCT06840496)Biomed Industries, Inc.2026-09-30
Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese (NCT06732245)Biomed Industries, Inc.2026-08-15
Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition (NCT06564753)Biomed Industries, Inc.2024-07-19
Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus (NCT06615700)Biomed Industries, Inc.2024-05-06
To Study the Efficacy & Safety of Oral NA-921 (Bionetide) in Girls and Women with Rett Syndrome (NCT06849973)Biomed Industries, Inc.2024-03-15
NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection (NCT04452565)Biomed Industries, Inc.2022-06-15
A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (NCT04540185)Biomed Industries, Inc.2020-11-01
A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 (NCT03538522)Biomed Industries, Inc.2018-09-15

Track Biomed Industries, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.